Faculty of Health, University of Plymouth, Devon, United Kingdom.
The Centre for Advancing Practice, Health Education England, Liverpool, United Kingdom.
Seizure. 2022 Jul;99:54-67. doi: 10.1016/j.seizure.2022.05.009. Epub 2022 May 13.
Clinical trials on childhood epilepsy treated with ketogenic diet (KD) use a wide range of outcomes, however, patients and decision-makers often do not perceive the outcomes used as the most important. We sought parental opinion on outcomes of importance and compared these to outcomes reported in published research.
Ethical approval (London-Surrey-REC19/LO/1680). A scoping review identified outcomes reported in previous studies of childhood epilepsy and KD. Parents were recruited from nine KD centres (UK), charities and social media (international), then interviewed (Jan-April 2020) to explore priority outcomes. Content analysis identified all outcomes in transcripts. Parent identified outcomes were compared with those in the scoping review. Outcomes were collated and grouped into domains according to the COMET Taxonomy.
Of 2663 articles;147 met inclusion criteria. 921 verbatim outcomes were sorted into 90 discrete outcomes, reduced to 70 in consultation with the study advisory group, then classified into 21 domains. Parents (n = 21) identified 39 outcomes as important from the scoping review and seven new outcomes. They prioritised both physiological and functional outcomes in contrast to past studies, which prioritised physiological outcomes.
Little consistency exists in the outcomes used in childhood epilepsy and KD research. Those traditionally used do not adequately reflect parents' important outcomes for their child. Clinical trials should consider the broader priorities of parents when choosing outcomes, in particular, functional outcomes. Identified outcomes will inform an international two-round Delphi-study with parent, professional and researcher participants to develop a core outcome set for this clinical area (COMET registration #1116).
针对采用生酮饮食(KD)治疗儿童癫痫的临床试验使用了广泛的结局指标,但患者和决策者通常并不认为所使用的结局指标是最重要的。我们旨在征求家长对重要结局指标的意见,并将这些意见与已发表研究中报告的结局指标进行比较。
伦理批准(伦敦-萨里-REC19/LO/1680)。通过范围界定审查,确定了以往儿童癫痫和 KD 研究报告的结局指标。从 9 个 KD 中心(英国)、慈善机构和社交媒体(国际)招募家长,然后(2020 年 1 月至 4 月)进行访谈,以探讨优先结局指标。内容分析从转录本中确定了所有的结局指标。将家长确定的结局指标与范围界定审查中的结局指标进行比较。根据 COMET 分类法将结局指标进行整理和分组。
在 2663 篇文章中;有 147 篇符合纳入标准。从纳入的研究中提取了 921 个原始结局指标,并将其分为 90 个离散结局指标,在与研究咨询小组协商后减少至 70 个,然后分为 21 个领域。家长(n=21)从范围界定审查中确定了 39 个重要结局指标和 7 个新结局指标。与以往研究侧重于生理结局指标不同,他们更注重生理和功能结局指标。
儿童癫痫和 KD 研究中使用的结局指标之间几乎没有一致性。传统上使用的结局指标不能充分反映家长对孩子的重要结局指标。临床试验在选择结局指标时,应考虑家长的广泛需求,特别是功能结局指标。确定的结局指标将为具有家长、专业人员和研究人员参与的国际两轮 Delphi 研究提供信息,以便为该临床领域制定核心结局集(COMET 注册 #1116)。